A study to investigate the safety, tolerability, and pharmacokinetics (PK) of oral AZD6793 in healthy subjects

Trial Identifier: D7860C00001
Sponsor: AstraZeneca
NCTID:: NCT05662033
Start Date: December 2022
Primary Completion Date: August 2023
Study Completion Date: August 2023

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
GB Harrow, GB, HA1 3UJ